Kids & teens (for parents) · Alabama
Studies for children and teens in Alabama
These studies only enroll people under 18. A parent or legal guardian gives permission, and children old enough to understand are asked for their own agreement (assent).
43 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
Intra-Cellular Therapies, Inc.
- Location
- Dothan, AL + 27 other US sites
- Eligibility basics
- Ages 5–17
- RecruitingPhase 4
Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age
CorMedix Therapeutics
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Up to age 17
- RecruitingPhase 3
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
Pfizer
- Location
- Birmingham, AL + 12 other US sites
- Eligibility basics
- Ages 6–11
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
Janssen Research & Development, LLC
- Location
- Birmingham, AL + 9 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
AbbVie
- Location
- Huntsville, AL + 87 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Incyte Corporation
- Location
- Birmingham, AL + 65 other US sites
- Eligibility basics
- Ages 2–11
- RecruitingPhase 3
A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
Takeda
- Location
- Birmingham, AL + 9 other US sites
- Eligibility basics
- Up to age 17
- RecruitingPhase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Eli Lilly and Company
- Location
- Birmingham, AL + 28 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 1/Phase 2
Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy
Ferring Pharmaceuticals
- Location
- Mobile, AL + 3 other US sites
- Eligibility basics
- Ages 1–8
- RecruitingPhase 3
A Study of Depemokimab in Participants of 6 to 11 Years of Age
GlaxoSmithKline
- Location
- Mobile, AL + 2 other US sites
- Eligibility basics
- Ages 6–11
- RecruitingPhase 3
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Alkermes, Inc.
- Location
- Dothan, AL + 14 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 3
Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
Octapharma
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
LEO Pharma
- Location
- Birmingham, AL + 13 other US sites
- Eligibility basics
- Ages 6 mo–11
- RecruitingPhase 3
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Vanda Pharmaceuticals
- Location
- Dothan, AL + 18 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Sun Pharmaceutical Industries, Inc.
- Location
- Birmingham, AL + 53 other US sites
- Eligibility basics
- Ages 12–17
- Recruiting
Evaluation of Accuracy of the Owlet OSS 3.0 Sensor in the Neonatal Population
Owlet Baby Care, Inc.
- Location
- Birmingham, AL + 1 other US site
- Eligibility basics
- Ages 0 mo–1 mo
- RecruitingHealthy volunteers
Wavelength Intervention for Nearsighted Kids
University of Alabama at Birmingham
- Location
- Birmingham, AL
- Eligibility basics
- Ages 7–12
- RecruitingHealthy volunteers
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
University of Alabama at Birmingham
- Location
- Birmingham, AL + 1 other US site
- Eligibility basics
- Ages 1 mo–5 mo
- RecruitingHealthy volunteersPhase 3
Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial
Ohio State University
- Location
- Birmingham, AL + 11 other US sites
- Eligibility basics
- Ages 6–11